Jillian GENTILE
2Patents
1h-index
4Co-inventors
33Inventor score
Filing activity: Jul 27, 2018 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11365241B2 | High concentration anti-C5 antibody formulations | Emerging Cross-Sectional Technologies | 2 | Active |
| US12012448B2 | High concentration anti-C5 antibody formulations | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.